https://www.zacks.com/stock/news/2219670/t-rowe-price-trow-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2219670
Feb 01, 2024 - T. Rowe Price (TROW) is expected to have witnessed an improvement in AUM in the fourth quarter of 2023 due to favourable equity market performance partially offset by net outflows.
zc:-1444630457733048380
0
https://www.zacks.com/stock/news/2219608/t-rowe-price-trow-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219608
Feb 01, 2024 - T. Rowe (TROW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:7236407796846359591
0
https://seekingalpha.com/news/4062217-samsung-ct-investors-pushing-for-dividends-share-buybacks?source=feed_sector_healthcare
Feb 02, 2024 - Investors urge Samsung to increase dividends and begin share repurchase plan.
0
sa:-8581781371916253248
0
https://www.fool.com/investing/2024/02/04/want-to-gain-1000-in-annual-dividend-income-invest/?source=iedfolrf0000001
Feb 04, 2024 - Building up a passive income stream could be easier than you expect.
0
fool:-2377069497975048277
0
https://www.zacks.com/stock/news/2221922/bristol-myers-bmy-tsvt-car-t-cell-therapy-to-face-fda-s-odac?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221922
Feb 06, 2024 - Bristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review data supporting the label expansion for CAR T-cell therapy.
zc:8567294693272462537
0
https://www.zacks.com/stock/news/2223559/t-rowe-price-trow-q4-earnings-beat-estimates-aum-rises-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2223559
Feb 08, 2024 - T. Rowe Price's (TROW) Q4 earnings beat estimates on increased net revenues, an improvement in AUM and a decline in expenses. A rise in cash and cash equivalents will help it continue investing.
zc:-6853405466055614972
0
https://www.fool.com/investing/2024/02/12/3-cheap-tech-stocks-to-buy-right-now/?source=iedfolrf0000001
Feb 12, 2024 - IBM, AT&T, and Cisco are all attractive safe haven plays.
0
fool:-8634066573489740201
0
https://www.zacks.com/stock/news/2227782/want-better-returns-don-t-ignore-these-2-consumer-discretionary-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2227782
Feb 19, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
zc:3326214368992771080
0
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
zc:-4727743462274195510
0
https://www.zacks.com/stock/news/2236364/w-t-wti-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2236364
Mar 05, 2024 - While the top- and bottom-line numbers for W&T (WTI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-7396144779111220938
0